Next Phase in Effective Cost Control in Health Care

In this Viewpoint, Ezekiel Emanuel and colleagues make policy recommendations to control continued growth in health care spending, including national US drug price negotiation, linking benchmarks for cost growth to economic growth and population aging, expansion of alternative payment models to priv...

Full description

Saved in:
Bibliographic Details
Published in:JAMA : the journal of the American Medical Association 2019-03, Vol.321 (12), p.1151-1152
Main Authors: Glickman, Aaron, DiMagno, Sarah S. P, Emanuel, Ezekiel J
Format: Article
Language:English
Subjects:
Aging
Benchmarks
Business competition
Economic development
Economic growth
Economic models
Federal legislation
Health care
Health care expenditures
Legislation
Prescription drugs
Pricing
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:In this Viewpoint, Ezekiel Emanuel and colleagues make policy recommendations to control continued growth in health care spending, including national US drug price negotiation, linking benchmarks for cost growth to economic growth and population aging, expansion of alternative payment models to private health care markets, and federal antitrust legislation to address market consolidation that reduces competition and increases prices.
ISSN:0098-7484
1538-3598
DOI:10.1001/jama.2019.1608